343 related articles for article (PubMed ID: 26112940)
1. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Prokhorova IV; Solyanik GI
Exp Oncol; 2016 Sep; 38(3):176-80. PubMed ID: 27685525
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment changes tumor cell sensitivity to action of energy metabolism modifiers.
Pyaskovskaya ON; Kolesnik DL; Prokhorova IV; Burlaka АP; Gorbach OI; Solyanik GI
Exp Oncol; 2020 Sep; 42(3):192-196. PubMed ID: 32996739
[TBL] [Abstract][Full Text] [Related]
4. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma.
Kolesnik DL; Pyaskovskaya ON; Yakshibaeva YR; Solyanik GI
Exp Oncol; 2019 Mar; 41(1):14-19. PubMed ID: 30932416
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of changes of antioxidant system indexes during the growth of two Lewis lung carcinoma variants.
Pyaskovskaya ON; Sorokina LV; Kolesnik DL; Boichuk IV; Melnikov OR; Solyanik GI
Exp Oncol; 2014 Mar; 36(1):29-33. PubMed ID: 24691281
[TBL] [Abstract][Full Text] [Related]
7. Aconitine-containing agent enhances antitumor activity of dichloroacetate against Ehrlich carcinoma.
Pyaskovskaya ON; Boychuk IV; Fedorchuk AG; Kolesnik DL; Dasyukevich OI; Solyanik GI
Exp Oncol; 2015 Sep; 37(3):192-6. PubMed ID: 26422103
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia enhances antitumor activity of dichloroacetate.
Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
[TBL] [Abstract][Full Text] [Related]
9. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of sodium dichloroacetate against glioma C6 depends on administration schedule and dosage.
Fedorchuk AG; Pyaskovskaya ON; Gorbik GV; Prokhorova IV; Kolesnik DL; Solyanik GI
Exp Oncol; 2016 Jun; 38(2):80-3. PubMed ID: 27356574
[TBL] [Abstract][Full Text] [Related]
11. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
[TBL] [Abstract][Full Text] [Related]
12. Effect of polyamine metabolism inhibitors on Lewis lung carcinoma growth and metastasis.
Samoilenko ОА; Milinevska OA; Karnaushenko OV; Shlyakhovenko VA; Zaletok SP
Exp Oncol; 2015 Jun; 37(2):151-3. PubMed ID: 26112945
[TBL] [Abstract][Full Text] [Related]
13. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
Pyaskovskaya ON; Dasyukevich OI; Kolesnik DL; Garmanchouk LV; Todor IN; Solyanik GI
Exp Oncol; 2007 Sep; 29(3):197-202. PubMed ID: 18004244
[TBL] [Abstract][Full Text] [Related]
14. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
[TBL] [Abstract][Full Text] [Related]
15. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba exocarp extracts induces apoptosis in Lewis lung cancer cells involving MAPK signaling pathways.
Cao C; Su Y; Han D; Gao Y; Zhang M; Chen H; Xu A
J Ethnopharmacol; 2017 Feb; 198():379-388. PubMed ID: 28115284
[TBL] [Abstract][Full Text] [Related]
17. Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol.
Kimura Y; Baba K
Int J Cancer; 2003 Sep; 106(3):429-37. PubMed ID: 12845685
[TBL] [Abstract][Full Text] [Related]
18. Effect of enterosorption on paraneoplastic syndrome manifestations in mice with highly angiogenic variant of Lewis lung carcinoma.
Sarnatskaya VV; Nikolaev VG; Yushko LA; Paziuk LM; Karaman ОМ; Fedosova NI; Kolesnik DL; Dasyukevich OI; Gorbik GV; Maslenny VN; Solyanik GI
Exp Oncol; 2015 Dec; 37(4):255-61. PubMed ID: 26710837
[TBL] [Abstract][Full Text] [Related]
19. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
[TBL] [Abstract][Full Text] [Related]
20. EFFECT OF LACTATE DEHYDROGENASE INHIBITION BY OXAMATE ON LEWIS LUNG CARCINOMA CELLS WITH DIFFERENT METASTATIC POTENTIAL.
Kolesnik DL; Prokhorova IV; Pyaskovskaya ON; Solyanik GI
Exp Oncol; 2023 Oct; 45(2):242-251. PubMed ID: 37824767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
